Table of Contents
Global Therapeutic Nuclear Medicines Sales Market Report 2019
1 Therapeutic Nuclear Medicines Market Overview
1.1 Therapeutic Nuclear MedicinesProduct Overview
1.2 Therapeutic Nuclear Medicines Segment by Type
1.2.1 Global Therapeutic Nuclear Medicines Sales Comparison by Types (2014-2025)
1.2.2 Beta Emitters
1.2.3 Alpha Emitters
1.2.4 Brachytherapy Products
1.3 Therapeutic Nuclear Medicines Segment by Application
1.3.1 Global Therapeutic Nuclear Medicines Sales Comparison by Application (2014-2025)
1.3.1 Thyroid
1.3.2 Bone Metastasis
1.3.3 Lymphoma
1.3.4 Endocrine Tumors
1.3.5 Others
1.4 Therapeutic Nuclear Medicines Market by Region
1.4.1 Global Therapeutic Nuclear Medicines Revenue Comparison by Region (2014-2025)
1.4.2 United States Therapeutic Nuclear Medicines Status and Prospect (2014-2025)
1.4.3 Europe Therapeutic Nuclear Medicines Status and Prospect (2014-2025)
1.4.4 China Therapeutic Nuclear Medicines Status and Prospect (2014-2025)
1.4.5 Japan Therapeutic Nuclear Medicines Status and Prospect (2014-2025)
1.4.6 Southeast Asia Therapeutic Nuclear Medicines Status and Prospect (2014-2025)
1.4.7 India Therapeutic Nuclear Medicines Status and Prospect (2014-2025)
1.5 Global Therapeutic Nuclear Medicines Sales and Revenue (2014-2025)
1.5.1 Global Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2025)
1.5.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate (2014-2025)
2 Therapeutic Nuclear Medicines by Company, Region, Type and Application
2.1 Global Therapeutic Nuclear Medicines Market Competition by Companies
2.1.1 Global Therapeutic Nuclear Medicines Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Company (2014-2019)
2.2 Global Therapeutic Nuclear Medicines Sales and Revenue by Region
2.2.1 Global Therapeutic Nuclear Medicines Sales Market Share by Region (2014-2019)
2.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2014-2019)
2.3 Global Therapeutic Nuclear Medicines Sales and Revenue by Type
2.3.1 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
2.3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2014-2019)
2.4 Global Therapeutic Nuclear Medicines Sales by Application
3 United States Therapeutic Nuclear Medicines Sales, Revenue and Price
3.1 United States Therapeutic Nuclear Medicines Sales and Revenue (2014-2019)
3.1.1 United States Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019)
3.1.2 United States Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019)
3.1.3 United States Therapeutic Nuclear Medicines Price Trend (2014-2019)
3.2 United States Therapeutic Nuclear Medicines Sales Market Share by Company
3.3 United States Therapeutic Nuclear Medicines Sales Market Share by Type
3.4 United States Therapeutic Nuclear Medicines Sales Market Share by Application
4 Europe Therapeutic Nuclear Medicines Sales, Revenue and Price
4.1 Europe Therapeutic Nuclear Medicines Sales and Value (2014-2019)
4.1.1 Europe Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019)
4.1.2 Europe Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019)
4.1.3 Europe Therapeutic Nuclear Medicines Price Trend (2014-2019)
4.2 Europe Therapeutic Nuclear Medicines Sales Market Share by Company
4.3 Europe Therapeutic Nuclear Medicines Sales Market Share by Type
4.4 Europe Therapeutic Nuclear Medicines Sales Market Share by Application
5 China Therapeutic Nuclear Medicines Sales, Revenue and Price
5.1 China Therapeutic Nuclear Medicines Sales and Revenue (2014-2019)
5.1.1 China Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019)
5.1.2 China Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019)
5.1.3 China Therapeutic Nuclear Medicines Price Trend (2014-2019)
5.2 China Therapeutic Nuclear Medicines Sales Market Share by Company
5.3 China Therapeutic Nuclear Medicines Sales Market Share by Type
5.4 China Therapeutic Nuclear Medicines Sales Market Share by Application
6 Japan Therapeutic Nuclear Medicines Sales, Revenue and Price
6.1 Japan Therapeutic Nuclear Medicines Sales and Value (2014-2019)
6.1.1 Japan Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019)
6.1.2 Japan Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019)
6.1.3 Japan Therapeutic Nuclear Medicines Price Trend (2014-2019)
6.2 Japan Therapeutic Nuclear Medicines Sales Market Share by Company
6.3 Japan Therapeutic Nuclear Medicines Sales Market Share by Type
6.4 Japan Therapeutic Nuclear Medicines Sales Market Share by Application
7 Southeast Asia Therapeutic Nuclear Medicines Sales, Revenue and Price
7.1 Southeast Asia Therapeutic Nuclear Medicines Sales and Value (2014-2019)
7.1.1 Southeast Asia Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Therapeutic Nuclear Medicines Price Trend (2014-2019)
7.2 Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Company
7.3 Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Type
7.4 Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Application
8 India Therapeutic Nuclear Medicines Sales, Revenue and Price
8.1 India Therapeutic Nuclear Medicines Sales and Value (2014-2019)
8.1.1 India Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019)
8.1.2 India Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019)
8.1.3 India Therapeutic Nuclear Medicines Price Trend (2014-2019)
8.2 India Therapeutic Nuclear Medicines Sales Market Share by Company
8.3 India Therapeutic Nuclear Medicines Sales Market Share by Type
8.4 India Therapeutic Nuclear Medicines Sales Market Share by Application
9 Company Profiles and Key Figures in Therapeutic Nuclear Medicines Business
9.1 Cardinal Health
9.1.1 Cardinal Health Therapeutic Nuclear Medicines Production Sites and Area Served
9.1.2 Therapeutic Nuclear Medicines Specification and Application
9.1.3 Cardinal Health Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Mallinckrodt
9.2.1 Mallinckrodt Therapeutic Nuclear Medicines Production Sites and Area Served
9.2.2 Therapeutic Nuclear Medicines Specification and Application
9.2.3 Mallinckrodt Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 GE Healthcare
9.3.1 GE Healthcare Therapeutic Nuclear Medicines Production Sites and Area Served
9.3.2 Therapeutic Nuclear Medicines Specification and Application
9.3.3 GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Lantheus Medical Imaging
9.4.1 Lantheus Medical Imaging Therapeutic Nuclear Medicines Production Sites and Area Served
9.4.2 Therapeutic Nuclear Medicines Specification and Application
9.4.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Bayer
9.5.1 Bayer Therapeutic Nuclear Medicines Production Sites and Area Served
9.5.2 Therapeutic Nuclear Medicines Specification and Application
9.5.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Bracco Imaging
9.6.1 Bracco Imaging Therapeutic Nuclear Medicines Production Sites and Area Served
9.6.2 Therapeutic Nuclear Medicines Specification and Application
9.6.3 Bracco Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Eczacibasi-Monrol Nuclear Products
9.7.1 Eczacibasi-Monrol Nuclear Products Production Sites and Area Served
9.7.2 Therapeutic Nuclear Medicines Specification and Application
9.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 Nordion
9.8.1 Nordion Therapeutic Nuclear Medicines Production Sites and Area Served
9.8.2 Therapeutic Nuclear Medicines Specification and Application
9.8.3 Nordion Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 Advanced Accelerator Applications
9.9.1 Advanced Accelerator Applications Therapeutic Nuclear Medicines Production Sites and Area Served
9.9.2 Therapeutic Nuclear Medicines Specification and Application
9.9.3 Advanced Accelerator Applications Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served
9.10 IBA Molecular Imaging
9.10.1 IBA Molecular Imaging Therapeutic Nuclear Medicines Production Sites and Area Served
9.10.2 Therapeutic Nuclear Medicines Specification and Application
9.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.10.4 Main Business and Markets Served
10 Therapeutic Nuclear Medicines Maufacturing Cost Analysis
10.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
10.4 Therapeutic Nuclear Medicines Industrial Chain Analysis
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Therapeutic Nuclear Medicines Distributors List
11.3 Therapeutic Nuclear Medicines Customers
12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors
13 Therapeutic Nuclear Medicines Market Forecast
13.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Price Forecast
13.1.1 Global Therapeutic Nuclear Medicines Sales Growth Forecast (2019-2025)
13.1.2 Global Therapeutic Nuclear Medicines Revenue Growth Forecast (2019-2025)
13.1.3 Global Therapeutic Nuclear Medicines Price Trend Forecast (2019-2025)
13.2 Global Therapeutic Nuclear Medicines Forecast by Region
13.2.1 Global Therapeutic Nuclear Medicines Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Therapeutic Nuclear Medicines Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Therapeutic Nuclear Medicines Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Therapeutic Nuclear Medicines Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Therapeutic Nuclear Medicines Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Therapeutic Nuclear Medicines Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Therapeutic Nuclear Medicines Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Therapeutic Nuclear Medicines Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Therapeutic Nuclear Medicines Forecast by Type
13.3.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2019-2025)
13.3.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2019-2025)
13.3.3 Global Therapeutic Nuclear Medicines Price Forecast by Type (2019-2025)
13.4 Global Therapeutic Nuclear Medicines Forecast by Application
14 Research Findings and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
【免責事項】
https://www.globalresearch.jp/disclaimer